Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled study
Authors
Ralph Fritsch (ORCID: https://orcid.org/0000-0001-9639-3213)
J. Frossard
Christoph Schlag (ORCID: https://orcid.org/0000-0003-3227-2724)
Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled study
Ralph Fritsch, J. Frossard, Christoph Schlag, Simon Bütikofer et al.
Journal
Frontiers in Oncology
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies
article
Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled study
Ralph Fritsch, J. Frossard, Christoph Schlag, Simon Bütikofer, Thibaud Koessler, Prof. Dr. Reiner Wiest, Tabea Pfister, André Moser, Samantha Chun Wai Chan, Sven Trelle, Martin D. Berger
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in OncologyVol. 15
Institutions
University of Bern (CH), University of Lucerne (CH), University of Zurich (CH), University Hospital of Bern (CH), University Hospital of Zurich (CH), University Hospital of Geneva (CH), Geneva College (US)